We have previously shown that the peroxidase inhibitor methimazole (1-methyl-2-mercapto imidazole; MMI) is a noncytotoxic inhibitor of melanin production in cultured B16 melanocytes. It was further demonstrated that the topical application of 5% MMI on brown guinea pig skin for 6 weeks causes a significant reduction in the amount of epidermal melanin, resulting in visually recognizable cutaneous depigmentation. Herein, we report a 27-year-old male with postinflammatory hyperpigmentation (due to acid burn), successfully treated with topical MMI as a new skin depigmenting agent. Topical 5% MMI caused a moderate to marked improvement of the hyperpigmented lesions within 6 weeks of once-daily application. Topical MMI was well tolerated by the patient and did not affect the level of serum thyroid hormones (free thyroxin, free triiodothyronine and the thyroid-stimulating hormone). Unlike most known depigmenting agents, such as hydroquinone and kojic acid, MMI is a noncytotoxic, nonmutagenic compound, and it is possible that MMI could serve as a novel agent for the treatment of hyperpigmentary disorders in human.

Keywords:
Methimazole, Postinflammatory hyperpigmentation, Melanin, Depigmenting agents
1.
Kasraee B, Hugin A, Tran C, Sorg O, Saurat JH: Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. J Invest Dermatol 2004;122:1338–1341.
2.
Kasraee B: Depigmentation of brown Guinea pig skin by topical application of methimazole. J Invest Dermatol 2002;118:205–207.
3.
Dooley TP: Topical skin depigmentation agents: current products and discovery of a novel inhibitor of melanogenesis. J Dermatol Treat 1997;8:275–279.
4.
Matsubayashi T, Sakaeda T, Kita T, Kurimoto Y, Nakamura T, Nishiguchi K, Fujita T, Kamiyama F, Yamamoto A, Okumura K: Intradermal concentration of hydroquinone after application of hydroquinone ointments is higher than its cytotoxic concentration. Biol Pharm Bull 2003;26:1365–1367.
5.
Passi S, Picardo M, Nazzaro-Porro M: Comparative cytotoxicity of phenols in vitro. Biochem J 1987;245:537–542.
6.
Curto EV, Kwong C, Hermersdorfer H, Glatt H, Santis C, Virador V, Hearing VJ Jr, Dooley TP: Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem Pharmacol 1999;57:663–672.
7.
Joseph P, Klein-Szanto AJ, Jaiswal AK: Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis. Br J Cancer 1998;78:312–320.
8.
Burdock GA, Soni MG, Carabin IG: Evaluation of health aspects of kojic acid in food. Regul Toxicol Pharmacol 2001;33:80–101.
9.
Maeda K, Fukuda M: Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 1996;276:765–769.
10.
Wei CI, Huang TS, Fernando SY, Chung KT: Mutagenicity studies of kojic acid. Toxicol Lett 1991;59:213–220.
11.
Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H: Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity. Pigment Cell Res 1998;11:12–17.
12.
Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM: beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. J Lipid Res 1992;33:1201–1209.
13.
Redoules D, Tarroux R, Assalit MF, Peri JJ: Characterisation and assay of five enzymatic activities in the stratum corneum using tape-strippings. Skin Pharmacol 1999;12:182–192.
14.
Akatsuka K, Hashimoto T, Takeuchi K, Ohhira M: Mutagenicity test of antithyroid agent,methimazole-dominant lethal mutation test on male mice (in Japanese). J Toxicol Sci 1979;4:127–137.
15.
Nagasaka A, Hidaka H: Effect of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodine peroxidase. J Clin Endocrinol Metab 1976;43:152–158.
16.
Kasraee B: Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents. Dermatology 2002;205:329–339.
17.
Bertazzo A, Costa CV, Allegri G, Favretto D, Traldi P: Application of matrix-assisted laser desorption/ionization mass spectrometry to the detection of melanins formed from Dopa and dopamine. J Mass Spectrom 1999;34:922–929.
18.
d’Ischia M, Napolitano A, Prota G: Peroxidase as an alternative to tyrosinase in the oxidative polymerization of 5,6-dihydroxyindoles to melanin(s). Biochim Biophys Acta 1991;1073:423–430.
19.
Jimbow K, Quevedo WC Jr, Prota G, Fitzpatrick TB: Biology of melanocytes; in Freedberg IM, et al. (eds): Fitzpatrick’s Dermatology in General Medicine. New York, McGraw-Hill, 1999, pp 192–219.
20.
Shibata T, Prota G, Mishima Y: Non-melanosomal regulatory factors in melanogenesis. J Invest Dermatol 1993;100:S274–S280.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.